High Tower Advisors, LLC Esperion Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

  • $84.5 Billion
  • Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 120,011 shares of ESPR stock, worth $348,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120,011
Previous 118,339 1.41%
Holding current value
$348,031
Previous $115,000 176.52%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
BUY
$0.98 - $2.84 $1,638 - $4,748
1,672 Added 1.41%
120,011 $318,000
Q2 2025

Aug 11, 2025
SELL
$0.73 - $1.41 $4,779 - $9,231
-6,547 Reduced 5.24%
118,339 $115,000
Q1 2025

May 12, 2025
BUY
$1.44 - $2.34 $29,700 - $48,262
20,625 Added 19.78%
124,886 $179,000
Q4 2024

Feb 07, 2025
SELL
$1.61 - $3.83 $2,109 - $5,017
-1,310 Reduced 1.24%
104,261 $229,000
Q3 2024

Nov 14, 2024
SELL
$1.61 - $2.73 $211,254 - $358,214
-131,214 Reduced 55.41%
105,571 $174,000
Q2 2024

Aug 13, 2024
BUY
$1.84 - $3.24 $91,298 - $160,765
49,619 Added 26.51%
236,785 $525,000
Q1 2024

May 06, 2024
BUY
$2.02 - $3.02 $277,945 - $415,542
137,597 Added 277.59%
187,166 $501,000
Q4 2023

Feb 12, 2024
BUY
$0.73 - $3.08 $18,404 - $77,649
25,211 Added 103.5%
49,569 $148,000
Q3 2023

Nov 08, 2023
BUY
$0.96 - $1.79 $734 - $1,369
765 Added 3.24%
24,358 $23,000
Q2 2023

Aug 14, 2023
BUY
$1.2 - $1.76 $28,311 - $41,523
23,593 New
23,593 $32,000
Q4 2020

Feb 10, 2021
SELL
$24.2 - $35.76 $792,622 - $1.17 Million
-32,753 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$31.18 - $52.71 $379,928 - $642,271
12,185 Added 59.24%
32,753 $1.22 Million
Q2 2020

Aug 10, 2020
SELL
$30.04 - $51.31 $751 - $1,282
-25 Reduced 0.12%
20,568 $1.06 Million
Q1 2020

May 21, 2020
SELL
$27.44 - $73.84 $34,986 - $94,146
-1,275 Reduced 5.83%
20,593 $650,000
Q4 2019

Feb 14, 2020
BUY
$35.4 - $59.82 $53,772 - $90,866
1,519 Added 7.46%
21,868 $1.3 Million
Q3 2019

Nov 12, 2019
SELL
$34.47 - $47.53 $267,694 - $369,117
-7,766 Reduced 27.62%
20,349 $744,000
Q2 2019

Aug 13, 2019
BUY
$40.1 - $52.33 $357,932 - $467,097
8,926 Added 46.52%
28,115 $1.3 Million
Q1 2019

May 15, 2019
BUY
$40.11 - $53.57 $49,255 - $65,783
1,228 Added 6.84%
19,189 $770,000
Q4 2018

Feb 14, 2019
BUY
$36.99 - $59.11 $15,202 - $24,294
411 Added 2.34%
17,961 $825,000
Q3 2018

Nov 09, 2018
BUY
$40.74 - $51.41 $714,987 - $902,245
17,550 New
17,550 $778,000

Others Institutions Holding ESPR

# of Institutions
213
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email